APOA1 Antikörper (AA 51-150)
Kurzübersicht für APOA1 Antikörper (AA 51-150) (ABIN728968)
Target
Alle APOA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 51-150
- 
                                            Kreuzreaktivität
- Huhn, Human, Maus, Ratte
- 
                                            Homologie
- Cow,Pig
- 
                                            Aufreinigung
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic peptide derived from human APOA1
- 
                                            Isotyp
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- 
                        WB 1:300-5000
 ELISA 1:500-1000
 FCM 1:20-100
 IHC-P 1:200-400
 IHC-F 1:100-500
 IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Konzentration
- 1 μg/μL
- 
                                            Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            Konservierungsmittel
- ProClin
- 
                                            Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 
                                            Haltbarkeit
- 12 months
 
- 
                                            
- 
    - 
                                            : "Proteome analysis of egg yolk after exposure to zinc oxide nanoparticles."    in: Theriogenology, Vol. 95, pp. 154-162, (2018)         (PubMed).        
 : "Comparative proteome analysis of abdominal adipose tissues between fat and lean broilers." in: Proteome science, Vol. 14, Issue 1, pp. 9, (2016) (PubMed).
 : "Apolipoprotein a-I is a potential mediator of remote ischemic preconditioning." in: PLoS ONE, Vol. 8, Issue 10, pp. e77211, (2013) (PubMed).
 : "Proteomic study on usnic-acid-induced hepatotoxicity in rats." in: Journal of agricultural and food chemistry, Vol. 60, Issue 29, pp. 7312-7, (2012) (PubMed).
 
 
- 
                                            : "Proteome analysis of egg yolk after exposure to zinc oxide nanoparticles."    in: Theriogenology, Vol. 95, pp. 154-162, (2018)         (PubMed).        
- 
    - APOA1 (Apolipoprotein A-I (APOA1))
- 
                                            Andere Bezeichnung
- APOA1
- 
                                            Hintergrund
- 
                        Synonyms: Apolipoprotein A-I, Apo-AI, ApoA-I, Apolipoprotein A1, APOA1 Background: Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. 
- 
                                            Gen-ID
- 335
- 
                                            UniProt
- P02647
- 
                                            Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
 Target
- 
                    
 
                                     
                                     
                                    